Literature DB >> 28191542

Loose ends in the eradication of Helicobacter pylori infection.

Armando Peixoto1, Marco Silva1, Rui Gaspar1, Rui Morais1, Rosa Ramalho1, Guilherme Macedo1, João Santos-Antunes1.   

Abstract

The eradication of Helicobacter pylori is essential for prevention and treatment of various conditions associated with this infection. However, its effectiveness is limited and influenced by factors linked to the bacteria and the host. In particular, influence of the biotype, smoking, diabetes mellitus, and previous treatment failure in eradication is understudied. Our center proposed to evaluate these aspects in a real life cohort by applying a questionnaire with demographic and lifestyle variables in patients who consecutively underwent urease breath test after the eradication therapy.

Entities:  

Keywords:  Helicobacter pylori; eradication; questionnaire

Year:  2016        PMID： 28191542      PMCID： PMC5290895          DOI： 10.1515/jtim-2016-0038

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN： 2224-4018


  9 in total

1.  Improving compliance with helicobacter pylori eradication therapy: when and how?

Authors:  John P Anthony O'Connor; Ikue Taneike; Colm O'Morain
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

2.  Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus.

Authors:  H H Xia; N J Talley; E P Kam; L J Young; J Hammer; M Horowitz
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

3.  Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection.

Authors:  Il-Ran Hwang; Tadashi Kodama; Shogo Kikuchi; Kyoko Sakai; Leif E Peterson; David Y Graham; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

4.  Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori.

Authors:  Mehmet Sargýn; Oya Uygur-Bayramicli; Haluk Sargýn; Ekrem Orbay; Dilek Yavuzer; Ali Yayla
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.

Authors:  Sara Padol; Yuhong Yuan; Marroon Thabane; Ireneusz T Padol; Richard H Hunt
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

Review 6.  Smoking increases the treatment failure for Helicobacter pylori eradication.

Authors:  Takeshi Suzuki; Keitaro Matsuo; Hidemi Ito; Akira Sawaki; Kaoru Hirose; Kenji Wakai; Shigeki Sato; Tsuneya Nakamura; Kenji Yamao; Ryuzo Ueda; Kazuo Tajima
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

7.  The eradication of Helicobacter pylori is affected by body mass index (BMI).

Authors:  Mohamed Abdullahi; Bruno Annibale; Danila Capoccia; Roberto Tari; Edith Lahner; John Osborn; Frida Leonetti; Carola Severi
Journal:  Obes Surg       Date:  2008-04-29       Impact factor: 4.129

8.  Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.

Authors:  T Furuta; M Sugimoto; N Shirai; F Matsushita; H Nakajima; J Kumagai; K Senoo; C Kodaira; M Nishino; M Yamade; M Ikuma; H Watanabe; K Umemura; T Ishizaki; A Hishida
Journal:  Aliment Pharmacol Ther       Date:  2007-09-01       Impact factor: 8.171

9.  Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.

Authors:  J Labenz; M Stolte; A L Blum; I Jorias; F Leverkus; M Sollböhmer; J Bertrams; G Börsch
Journal:  Gut       Date:  1995-07       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.